Diabetic Retinopathy & Anti-VEGF Intraocular Injections
Microvascular damage to the retina caused by chronic hyperglycemia, leading to diabetic macular edema (DME), retinal ischemia, and neovascularization.
Article Table of Contents
1. Comprehensive Overview
Diabetic Retinopathy (DR) is a progressive neurovascular complication of diabetes mellitus and a leading cause of preventable blindness in working-age adults.
Pathophysiology: Chronic hyperglycemia induces basement membrane thickening, pericyte loss, and capillary occlusion. Ensuing retinal ischemia upregulates Vascular Endothelial Growth Factor (VEGF) and inflammatory cytokines, increasing vascular permeability and stimulating pathologic angiogenesis.
Clinical Staging: 1. Non-Proliferative Diabetic Retinopathy (NPDR): Graded as mild, moderate, or severe based on microaneurysms, dot-and-blot hemorrhages, hard lipid exudates, cotton-wool spots (nerve fiber infarcts), and venous beading. 2. Diabetic Macular Edema (DME): Breakdown of the inner blood-retinal barrier causing fluid accumulation in the fovea, measurable on OCT; the leading cause of moderate visual loss across all stages. 3. Proliferative Diabetic Retinopathy (PDR): Ischemia-induced neovascularization of the disc (NVD) or elsewhere (NVE). Fragile vessels bleed into the vitreous cavity (vitreous hemorrhage) and proliferate with fibrovascular tissue, causing tractional retinal detachment (TRD) and neovascular glaucoma.
2. Symptoms & Warning Signs
If you observe any of the following symptoms repeatedly, an eye exam is strongly recommended:
- Early/Moderate NPDR: Completely asymptomatic despite active microvascular retinopathy
- Central visual blur, distortion, and reading difficulties caused by Diabetic Macular Edema (DME)
- Sudden emergence of dense dark cobwebs, floaters, or reddish haze indicating Vitreous Hemorrhage
- Metamorphopsia (distortion of straight lines into wavy lines)
- Decreased contrast sensitivity and color vision desaturation
- Abrupt, profound visual loss in severe vitreous hemorrhage or tractional retinal detachment
3. Causes & Risk Factors
- 1Chronic uncontrolled hyperglycemia and elevated glycated hemoglobin (HbA1c > 7.0%)
- 2Duration of diabetes mellitus (>10–15 years is the strongest predictor of retinopathy)
- 3Systemic co-morbidities: arterial hypertension and hyperlipidemia
- 4Diabetic nephropathy and presence of microalbuminuria/proteinuria
- 5Pregnancy in pre-existing diabetic women accelerating retinopathy progression
4. Treatments & Medical Management
5. Prevention & Daily Eye Care Advice
- Mandatory annual dilated fundus examination for all diabetic patients regardless of visual acuity
- Immediate fundus screening upon initial diagnosis of Type 2 diabetes; after 5 years in Type 1 diabetes
- Maintaining strict glycemic control (HbA1c < 7%) and avoiding glycemic variability
- Routine physical exercise and absolute smoking cessation
6. When to Seek Emergency Eye Care
Visit an immediate eye emergency center if you experience any of the following critical indicators:
- ⚠Sudden emergence of dark spots, floaters, or reddish cobwebs
- ⚠Sudden or progressive central visual blur or reading distortion
- ⚠Perception of a dark curtain or shadow across the visual field (retinal detachment warning)
- ⚠Over 12 months elapsed since last dilated fundus examination in a diabetic patient
7. Frequently Asked Questions
Q:Are intraocular eye injections painful?
No, intravitreal injections are performed in seconds under sterile conditions with high-potency topical anesthetic drops. Patients feel minimal pressure rather than sharp pain, making it a comfortable, sight-saving procedure.
Q:Why do I need a fundus exam when my vision is 20/20?
Because diabetic microvascular damage begins silently in the peripheral retina without degrading central 20/20 vision initially. Early detection allows timely intervention before irreversible macular damage occurs.
